Top Regulatory News Stories – Week Ending June 29, 2018

On Monday the FDA approved the first drug based on compounds found in marijuana. Epidiolex, made by GW Pharmaceuticals, was approved to treat two forms of severe childhood epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.   https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm611046.htm Achaogen, Inc. announced that the FDA has approved ZEMDRI™ (plazomicin) for adults with complicated urinary tract infections (cUTI), including pyelonephritis.[…]